跳至主要内容
临床试验/IRCT20200724048192N1
IRCT20200724048192N1招募中2 期

acetylcysteine as an adjuvant therapy in acute aluminum phosphide poisoning: A randomized clinical trial

Menoufia Faculty of Medicine0 个研究点目标入组 48 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 no limit(—)
性别
All

入选标准

  • History of taking aluminum phosphide tablet(s) and clinical manifestations of acute aluminum phosphide poisoning
  • Reliable identification of the compound either by the container brought by patient attendants or subsequent confirmation with positive silver nitrate test on gastric sample in case of oral route exposure

排除标准

  • Patients less than 12 years old
  • Pregnant and lactating women
  • Patients suffering from chronic diseases (e.g. diabetes mellitus, cardiovascular diseases, and hepatic or renal failure)
  • Tablet(s) was/were dissolved in water before ingestion
  • Ingestion of air-exposed aluminium phosphide tablets
  • Time passed since ingestion more than 8 hours
  • Patient who refused to participate

研究者

发起方
Menoufia Faculty of Medicine

相似试验